NEO
NeoGenomics, Inc.NASDAQHealthcare$8.00+0.25%ClosedMarket Cap: $207.7M
As of 2026-04-06
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-02-24 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-17 | Needham | maintain | Buy | Buy |
| 2026-01-12 | Needham | maintain | Buy | Buy |
| 2025-09-12 | TD Cowen | maintain | Buy | Buy |
| 2025-09-02 | Stephens & Co. | maintain | Overweight | Overweight |
| 2025-08-29 | Needham | maintain | Buy | Buy |
| 2025-08-04 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-07-30 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2025-07-29 | William Blair | downgrade | Market Perform | Outperform |
| 2025-07-29 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.31 | $874.2M | 8 |
| Sun Dec 31 | $0.44 | $953.9M | 2 |
| Mon Dec 31 | $0.62 | $1.03B | 1 |
| Tue Dec 31 | $0.81 | $1.11B | 1 |